Semnur Pharmaceuticals SMNR
OTC SMNR
$0.37 -0.01 (-2.63%)
At close: Oct 21, 2026 · 4:00 PM EDT

Semnur Pharmaceuticals (SMNR) Long-Term Debt Repayments (2022 - 2026)

Updated

Semnur Pharmaceuticals (SMNR) posted Long-Term Debt Repayments of $660,000 for Q2 2026, down 12.0% from the prior quarter.

Analysis

Semnur Pharmaceuticals (SMNR) Long-Term Debt Repayments (2022 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Long-Term Debt Repayments at Semnur Pharmaceuticals was $1.41 million; for FY2025, it was $961,000.

  • Annual Long-Term Debt Repayments shows a three-year compound annual growth rate of 58.8% (FY2022 to FY2025).
  • In prior years, Semnur Pharmaceuticals' Long-Term Debt Repayments was $240,020 in FY2022.
  • The Q2 2026 figure stands as the lowest quarterly Long-Term Debt Repayments since Q3 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 873.00 Mn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 1.00 Mn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 2.00 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 5.00 Mn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 20.00 Mn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 2.46 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 17.00 Mn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 Semnur Pharmaceuticals 85.18 Mn 84.92 Mn - 660,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 660,000.00
Mar 31, 2026 750,000.00
Sep 30, 2022 160,000.00
API Access

Semnur Pharmaceuticals Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=SMNR&period=max&api_key=YOUR_API_KEY